A genetic investigation of equine recurrent uveitis in the Icelandic horse breed.

This research seeks to understand the genetic factors that could potentially contribute to equine recurrent uveitis (ERU), an autoimmune eye disease, in Icelandic horses. Using gene mapping and sequencing, a significant variant was identified in the gene TIMP2, previously linked to ERU.

Understanding the Research Scope and Background

• The study aimed to understand if genetic factors play a significant role in development of equine recurrent uveitis (ERU), which is an autoimmune disease causing inflammation in the uveal tract of a horse’s eye.
• The focus of the study was the Icelandic horse breed. A total of 56 Icelandic horses in Denmark and the USA, including both disease-affected and healthy individuals, were chosen for this research.
• Earlier research has suggested that ERU’s underlying causes might include both genetic as well as environmental factors, providing the impetus for this more focused genetic study.

Methodology of the Study

• The researchers conducted a Genome-Wide Association Study (GWAS), a type of study that involves rapidly scanning markers across complete sets of DNA (or genomes) of many individuals to find genetic variations associated with a particular disease.
• The research used the GGP Equine 80K array, part of a high definition gene reader (Illumina Infinium HD Beadchip), using 40 horses from the initial 56.
• A complex statistical model (a mixed linear model analysis) was used to identify if there were any particular ‘Single Nucleotide Polymorphisms’ (SNPs) – variations occurring at a single position in a DNA sequence – that were significantly associated with the occurrence of ERU.

Findings and Interpretation

• The researchers found a single SNP on ECA 11 (identified as BIEC2_141650, or NC_009154.3:g.3817009A>G) that showed genome-wide significance. In simple terms, this means this particular variation was significantly associated with ERU in the sample group, over and above what one might expect by chance.
• This variant was located within an intron of the ‘Tissue Inhibitor of Metalloproteinase 2’ (TIMP2) gene, which has been previously implicated in ERU. Introns are non-protein-coding regions of genes.
• Despite further sequencing revealing a potential variant in the TIMP2 gene coding region, it turned out to be a synonymous mutation (it wouldn’t change the protein made by the gene). Also, its relationship with ERU wasn’t statistically significant.

Conclusions and Further Steps

• Even though a connection has been established between the TIMP2 gene and ERU, the significance of the synonymous mutation in the gene remains unclear, thus necessitating further investigation.
• The study also suggests that additional research involving a larger number of horses and more genetic markers could shed light on other genetic loci that might influence the risk of ERU in Icelandic horses.